Selectis Health (GBCS) AI Stock Analysis

• Market Cap: $4.63M
• Dividend Yield: N/A
• Average Volume (3M): 155.00
• Price to Earnings (P/E): ―
• Beta (1Y): -1.55
• Revenue Growth: 7.36%
• EPS Growth: 39.10%
• Country: US
• Employees: 616
• Sector: Healthcare
• Sector Strength: 38
• Industry: Medical - Care Facilities
• EPS (TTM): -0.80
• Shares Outstanding: 3,067,059
• 10 Day Avg. Volume: 466
• 30 Day Avg. Volume: 155
• PEG Ratio: -0.05
• Price to Book (P/B): -1.25
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -3.63
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Selectis Health is facing significant financial difficulties, highlighted by consistent net losses, high leverage, and negative equity, which severely impact its financial stability. The bearish technical indicators and negative valuation metrics further underscore the challenges facing the company. The lack of earnings call data or corporate events means these factors are not mitigating the overall negative outlook.

Selectis Health Business Overview & Revenue Model

Company Description

Selectis Health (GBCS) is a healthcare company operating within the long-term care sector. The company primarily focuses on providing skilled nursing and rehabilitation services. It offers a range of healthcare services designed to meet the needs of individuals requiring extended care, rehabilitation, or recovery support, ensuring a high standard of care and patient satisfaction across its facilities.

How the Company Makes Money

Selectis Health generates revenue through the operation of its skilled nursing facilities, where it provides long-term care and rehabilitation services to patients. The company earns money by billing for services rendered, which may include direct payments from patients, reimbursements from insurance companies, and government healthcare programs such as Medicare and Medicaid. Key revenue streams include daily rates for room and board, therapy services, and ancillary services like medication management. Additionally, partnerships with healthcare providers and networks may contribute to patient referrals and occupancy rates, directly impacting revenue.

Selectis Health Financial Statement Overview

Summary

Selectis Health faces significant financial challenges with consistent net losses, high leverage, and negative equity. Despite some revenue growth, profitability and liquidity issues persist, requiring strategic restructuring to enhance financial health.

Income Statement

Selectis Health shows fluctuating revenue growth with a significant increase in 2024. However, the company continues to experience negative net income and EBIT, indicating ongoing profitability challenges. The negative EBIT and EBITDA margins over the years highlight operational inefficiencies.

Balance Sheet

The company's financial stability is weak, characterized by high levels of debt and negative stockholders' equity in 2024, suggesting insolvency risk. The negative ROE reflects the inability to generate profits from shareholders' investments, and the equity ratio is negative, further indicating financial distress.

Cash Flow

While Selectis Health has experienced some growth in free cash flow in 2024, it remains negative, limiting financial flexibility. The negative operating cash flow to net income ratio further underscores cash management issues, posing liquidity challenges.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
39.49M	36.78M	37.33M	27.77M	20.93M
	Gross Profit
39.49M	5.41M	7.47M	6.30M	7.54M
	EBIT
-2.73M	-8.96M	-118.11K	-94.47K	3.37M
	EBITDA
1.19M	-7.29M	1.51M	1.00M	4.96M
	Net Income Common Stockholders
-2.42M	-3.97M	-2.30M	-5.38M	815.45K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
680.33K	1.48M	1.42M	3.96M	3.59M
	Total Assets
33.45M	40.67M	42.49M	46.92M	45.93M
	Total Debt
19.88M	37.25M	37.89M	38.50M	39.50M
	Net Debt
19.20M	35.76M	36.47M	34.56M	35.94M
	Total Liabilities
38.86M	43.64M	41.54M	43.82M	42.72M
	Stockholders Equity
-5.41M	-2.96M	952.84K	3.10M	3.41M
Cash Flow		Free Cash Flow
-1.86M	506.86K	-527.51K	-790.50K	1.75M
	Operating Cash Flow
-1.82M	536.67K	-305.15K	-270.93K	2.73M
	Investing Cash Flow
2.45M	-29.80K	-222.36K	-519.58K	-1.57M
	Financing Cash Flow
-1.54M	-618.74K	-1.85M	1.61M	1.82M

Selectis Health Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GBCS, the sentiment is Negative. The current price of 2 is below the 20-day moving average (MA) of 2.05, below the 50-day MA of 2.13, and above the 200-day MA of 1.92, indicating a bearish trend. The MACD of -0.08 indicates Positive momentum. The RSI at 3.12 is Positive, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GBCS.

Selectis Health Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AMS	54 Neutral	$19.22M	8.04	6.16%	―	35.25%	175.21%
Sector *	52 Neutral	$5.15B	3.05	-44.13%	2.84%	16.42%	-0.48%
CCEL	51 Neutral	$40.01M	396.00	93.38%	9.98%	2.33%	―
SYRA	45 Neutral	$964.68K	―	-94.29%	―	33.04%	39.30%
GBCS	38 Underperform	$4.63M	―	113.38%	―	7.36%	39.10%
MODV	33 Underperform	$14.07M	―	-951.52%	―	-0.70%	-2.38%
CCM	32 Underperform	$36.51M	―	14.03%	―	-29.82%	-2.57%